ClinicalTrials.gov
ClinicalTrials.gov Menu

Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer (CLASSIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00411229
Recruitment Status : Completed
First Posted : December 13, 2006
Last Update Posted : February 20, 2013
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Sanofi